Most of the evidence for the Wegovy pill comes from the OASIS 4 trial, a 71week, doubleblind, randomised, placebocontrolled trial involving 205 participants with a BMI of 30 or over, without diabetes [3]
Medical weight loss may be a good fit for patients who want professional guidance, have struggled to lose weight on their own, or need a more structured plan
Am J Physiol Endocrinol Metab 2013
These findings highlight that GLP-1-RA such as Ex-4 can promote hMSC proliferation, while native GLP-1 forms and Liraglutide predominantly exert inhibitory effects on proliferation and glucose uptake, with varying results under different conditions, highlighting their context-dependent role in hMSC behavior and metabolic regulation
Her pulmonologist suggested bariatric surgery but couldnt get Finleys insurer to cover it